vs

Side-by-side financial comparison of GERMAN AMERICAN BANCORP, INC. (GABC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $126.7M, roughly 1.6× GERMAN AMERICAN BANCORP, INC.). GERMAN AMERICAN BANCORP, INC. runs the higher net margin — 28.2% vs 6.7%, a 21.5% gap on every dollar of revenue. On growth, GERMAN AMERICAN BANCORP, INC. posted the faster year-over-year revenue change (39.7% vs 13.6%). GERMAN AMERICAN BANCORP, INC. produced more free cash flow last quarter ($154.0M vs $17.6M). Over the past eight quarters, GERMAN AMERICAN BANCORP, INC.'s revenue compounded faster (22.7% CAGR vs 14.4%).

American Express Company or Amex is an American bank holding company and multinational financial services corporation that specializes in payment cards. It is headquartered at 200 Vesey Street, also known as American Express Tower, in the Battery Park City neighborhood of Lower Manhattan.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

GABC vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.6× larger
RGEN
$197.9M
$126.7M
GABC
Growing faster (revenue YoY)
GABC
GABC
+26.0% gap
GABC
39.7%
13.6%
RGEN
Higher net margin
GABC
GABC
21.5% more per $
GABC
28.2%
6.7%
RGEN
More free cash flow
GABC
GABC
$136.4M more FCF
GABC
$154.0M
$17.6M
RGEN
Faster 2-yr revenue CAGR
GABC
GABC
Annualised
GABC
22.7%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GABC
GABC
RGEN
RGEN
Revenue
$126.7M
$197.9M
Net Profit
$35.7M
$13.3M
Gross Margin
52.5%
Operating Margin
34.6%
9.0%
Net Margin
28.2%
6.7%
Revenue YoY
39.7%
13.6%
Net Profit YoY
53.7%
143.9%
EPS (diluted)
$0.98
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GABC
GABC
RGEN
RGEN
Q4 25
$126.7M
$197.9M
Q3 25
$126.5M
$188.8M
Q2 25
$123.2M
$182.4M
Q1 25
$111.1M
$169.2M
Q4 24
$90.7M
$174.1M
Q3 24
$88.5M
$154.9M
Q2 24
$90.5M
$154.1M
Q1 24
$84.1M
$151.3M
Net Profit
GABC
GABC
RGEN
RGEN
Q4 25
$35.7M
$13.3M
Q3 25
$35.1M
$14.9M
Q2 25
$31.4M
$14.9M
Q1 25
$10.5M
$5.8M
Q4 24
$23.2M
$-30.3M
Q3 24
$21.0M
$-654.0K
Q2 24
$20.5M
$3.3M
Q1 24
$19.0M
$2.1M
Gross Margin
GABC
GABC
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
GABC
GABC
RGEN
RGEN
Q4 25
34.6%
9.0%
Q3 25
34.6%
8.9%
Q2 25
31.8%
7.6%
Q1 25
12.0%
3.9%
Q4 24
31.6%
-17.7%
Q3 24
29.0%
-5.1%
Q2 24
29.4%
1.0%
Q1 24
27.6%
1.3%
Net Margin
GABC
GABC
RGEN
RGEN
Q4 25
28.2%
6.7%
Q3 25
27.7%
7.9%
Q2 25
25.5%
8.2%
Q1 25
9.5%
3.4%
Q4 24
25.6%
-17.4%
Q3 24
23.8%
-0.4%
Q2 24
22.7%
2.2%
Q1 24
22.6%
1.4%
EPS (diluted)
GABC
GABC
RGEN
RGEN
Q4 25
$0.98
$0.24
Q3 25
$0.94
$0.26
Q2 25
$0.84
$0.26
Q1 25
$0.30
$0.10
Q4 24
$0.79
$-0.55
Q3 24
$0.71
$-0.01
Q2 24
$0.69
$0.06
Q1 24
$0.64
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GABC
GABC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$100.0M
$542.2M
Stockholders' EquityBook value
$1.2B
$2.1B
Total Assets
$8.4B
$2.9B
Debt / EquityLower = less leverage
0.09×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GABC
GABC
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
GABC
GABC
RGEN
RGEN
Q4 25
$100.0M
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$114.6M
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GABC
GABC
RGEN
RGEN
Q4 25
$1.2B
$2.1B
Q3 25
$1.1B
$2.1B
Q2 25
$1.1B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$715.1M
$2.0B
Q3 24
$744.6M
$2.0B
Q2 24
$687.8M
$2.0B
Q1 24
$655.3M
$2.0B
Total Assets
GABC
GABC
RGEN
RGEN
Q4 25
$8.4B
$2.9B
Q3 25
$8.4B
$2.9B
Q2 25
$8.3B
$2.9B
Q1 25
$8.4B
$2.9B
Q4 24
$6.3B
$2.8B
Q3 24
$6.3B
$2.8B
Q2 24
$6.2B
$2.9B
Q1 24
$6.1B
$2.8B
Debt / Equity
GABC
GABC
RGEN
RGEN
Q4 25
0.09×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.16×
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GABC
GABC
RGEN
RGEN
Operating Cash FlowLast quarter
$159.3M
$25.7M
Free Cash FlowOCF − Capex
$154.0M
$17.6M
FCF MarginFCF / Revenue
121.6%
8.9%
Capex IntensityCapex / Revenue
4.2%
4.1%
Cash ConversionOCF / Net Profit
4.46×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$267.0M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GABC
GABC
RGEN
RGEN
Q4 25
$159.3M
$25.7M
Q3 25
$51.8M
$48.1M
Q2 25
$26.9M
$28.6M
Q1 25
$37.9M
$15.0M
Q4 24
$95.8M
$39.2M
Q3 24
$24.5M
$49.3M
Q2 24
$18.7M
$42.2M
Q1 24
$23.9M
$44.7M
Free Cash Flow
GABC
GABC
RGEN
RGEN
Q4 25
$154.0M
$17.6M
Q3 25
$50.1M
$43.4M
Q2 25
$26.2M
$21.5M
Q1 25
$36.7M
$11.4M
Q4 24
$90.7M
$33.6M
Q3 24
$23.0M
$42.3M
Q2 24
$17.0M
$37.4M
Q1 24
$22.6M
$36.4M
FCF Margin
GABC
GABC
RGEN
RGEN
Q4 25
121.6%
8.9%
Q3 25
39.6%
23.0%
Q2 25
21.2%
11.8%
Q1 25
33.0%
6.8%
Q4 24
100.1%
19.3%
Q3 24
26.0%
27.3%
Q2 24
18.8%
24.3%
Q1 24
26.9%
24.0%
Capex Intensity
GABC
GABC
RGEN
RGEN
Q4 25
4.2%
4.1%
Q3 25
1.3%
2.5%
Q2 25
0.6%
3.9%
Q1 25
1.1%
2.1%
Q4 24
5.6%
3.2%
Q3 24
1.7%
4.5%
Q2 24
1.8%
3.1%
Q1 24
1.5%
5.5%
Cash Conversion
GABC
GABC
RGEN
RGEN
Q4 25
4.46×
1.93×
Q3 25
1.48×
3.23×
Q2 25
0.86×
1.92×
Q1 25
3.61×
2.57×
Q4 24
4.13×
Q3 24
1.16×
Q2 24
0.91×
12.70×
Q1 24
1.25×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons